Under the patronage of Prof. Mohamed Diaa Zain El-Abedeen, President of Ain Shams University, Prof. Ali El-Anwar, Dean of the Faculty of Medicine and Chairman of the Board of Directors of University Hospitals, inaugurated the activities of the first Endocrinology & Diabetes Annual Congress (ENDO SHAMS) organized by the Department of Endocrinology and Diabetes at the Internal Medicine Hospital, Faculty of Medicine, Ain Shams University.

In the presence of a group of prominent experts and doctors, including Prof. Sherif Wadea, Professor of Intensive Care at Ain Shams University and Advisor to the Minister of Health for Emergencies, Prof. Amr Hassan, Professor of Obstetrics and Gynecology at Cairo University and Advisor to the Minister of Health and Population, Prof. Hatem El Gamal, Head of the IVF and In Vitro Fertilization Unit at Ain Shams University and Prof. Tarek Youssef, Director of the University Internal Medicine Hospital.

The conference was supervised by Dr. Tarek Maged, Head of Departments, while Dr. Salwa Siddek, Head of the Endocrinology Unit at Ain Shams University, assumed the position of Conference Chairman.

A number of professors of endocrinology and diabetes, obstetrics and gynecology, therapeutic nutrition, psychiatry, interventional radiology, the Department of Allergy and Immunology and the Department of Ophthalmology participated in the events, where ideas and experiences were exchanged to address health challenges related to endocrine diseases and diabetes.

The conference concluded with a number of recommendations, the most important of which is the need for early detection and diagnosis of blood sugar, while continuing to support the One Hundred Million Health Initiative, which is important to avoid complications, as well as the necessity of healthy food and light exercise to lose weight in addition to medical treatment.

He also stressed that the use of modern medications that affect the kidneys and heart leads to a decrease in the rates of diabetes's effect on the kidneys and heart and the occurrence of strokes, and monitoring the blood sugar level with CGM devices (continuous glucose monitoring) is important for type 1 diabetes patients and type 2 diabetes patients who are committed to insulin.

He discussed the extension of scientific research in the aspects related to endocrinology and the effects of hormones and gene therapy and attempts to apply them in a thoughtful manner following the state's approach to scientific research.

He recommended that blood pressure is a chronic disease that must be accurately diagnosed and appropriate treatment prescribed to reduce the incidence of kidney disease and heart attacks, as a large percentage of the causes of pressure are due to adrenal gland tumors and it is necessary to note and consult specialists in the event of non-response to initial and conventional treatments.

As for cases of pregnancy, thyroid and adrenal gland disease and gestational diabetes, coordination was made with the professors of obstetrics and gynecology to establish a joint clinic to follow up on these cases in order to achieve the most important benefit for the mother and the fetus.

He also recommended the necessity of diagnosing diseases of high blood fats and cholesterol that lead to atherosclerosis, to determine the therapeutic dose, as the expected benefit from their use is higher than the occurrence of some side effects, which the doctor diagnoses and reduces their effects, and thyroid medications should be taken on an empty stomach and away from any other medications. He also recommended the necessity of periodic examination of the feet to ensure the safety of blood vessels and peripheral nerves to maintain the safety of the feet.

Finally, radiofrequency ablation of benign thyroid nodules has become a modern, safe and effective mechanism with fewer side effects.

These recommendations constitute an intensive plan to improve the care of endocrine and diabetes patients, and to enhance scientific research in this field, in line with national efforts in health care.